Indice Resistivo Uretrale (URI): Un Nuovo Parametro per la Diagnosi di Ostruzione Uretrale (URI)
Indice di Resistenza Uretrale (URI): Un Nuovo Parametro Uroflussimetrico nella Diagnosi Non Invasiva dell'Ostruzione Uretrale
This prospective observational study aims to evaluate the diagnostic accuracy of a new, non-invasive uroflowmetry parameter called the Urethral Resistive Index (URI) for detecting urethral stricture in men. Currently, diagnosing urethral stricture often requires invasive procedures like surgery or pressure-flow studies. This research seeks to develop URI as a practical and painless screening tool that could reduce the need for such invasive interventions.
Study Procedures:
A total of 60 male participants (30 with suspected urethral stricture and 30 healthy volunteers) will be enrolled. Participants will undergo two standard, non-invasive uroflowmetry (voiding) tests. The first test is a routine natural voiding session. The second test involves a "forced voiding" (Valsalva maneuver) once the participant feels a sufficient urge to urinate again. The URI is then calculated by comparing the flow rates of these two sessions.
Goals and Benefits: The primary goal is to determine the optimal "cut-off" value of the URI that accurately identifies a surgically proven urethral stricture. By demonstrating URI's effectiveness, the study aims to expedite the diagnostic process and spare patients from unnecessary invasive tests. The procedure involves minimal risk, primarily temporary discomfort or psychological stress during the voiding tests
Panoramica dello studio
Stato
Stato
Condizioni
Condizioni
Intervento / Trattamento
Intervento / Trattamento
Descrizione dettagliata
This methodological study is designed as a prospective, cross-sectional, and observational diagnostic accuracy study. The primary objective is to evaluate the clinical validity of the Urethral Resistive Index (URI), a novel non-invasive parameter, in the diagnosis of urethral stricture.
Study Population and Groups:
The study will include a total of 60 male participants aged between 18 and 80 years.
Stricture Group (n=30): Patients planned for surgery (urethroplasty or internal urethrotomy) due to suspected urethral stricture, where the presence of the stricture is confirmed intraoperatively.
Control Group (n=30): Healthy male volunteers without lower urinary tract symptoms, matched for age.
Methodology: The study focuses on comparing standard uroflowmetry with "forced" uroflowmetry using the Valsalva maneuver. All clinical and uroflowmetric parameters will be collected at the Ankara Bilkent City Hospital Urology Clinic.
Natural Uroflowmetry: Participants will perform a standard uroflowmetry test. Forced Uroflowmetry: After reaching sufficient bladder fullness again, participants will perform a second test using the Valsalva maneuver (forced voiding).
Calculation: The URI will be calculated using the formula:
URI= Qmax,forced/ Qmax,normal
Statistical Analysis: The diagnostic performance of the URI will be evaluated using Receiver Operating Characteristic (ROC) curve analysis. The Area Under the Curve (AUC) will be calculated, and the optimal cut-off value for determining urethral stricture will be identified with corresponding sensitivity and specificity values. Correlation between URI and clinical symptom scores, such as the International Prostate Symptom Score (IPSS), will also be analyzed.
Tipo di studio
Tipo di studio
Iscrizione (Stimato)
Iscrizione
Contatti e Sedi
Contatto studio
Contatto studio
- Nome: Yusuf Gökkurt
- Numero di telefono: +90-506-791-0557
- Email: yusufgokkurt@gmail.com
Luoghi di studio
-
-
Universiteler
-
Ankara, Universiteler, Turchia (Türkiye), 06800
- Reclutamento
- Ankara Bilkent City Hospital
-
Contatto:
- Yusuf Gökkurt, MD
- Numero di telefono: +90 506 791 0557
- Email: yusufgokkurt@gmail.com
-
-
Criteri di partecipazione
Criteri di ammissibilità
Criteri di ammissibilità
Età idonea allo studio
Accetta volontari sani
Sessi ammissibili allo studio
Metodo di campionamento
Popolazione di studio
The study population consists of 60 male participants, aged 18 to 80 years, recruited from the Urology Outpatient Clinic at Ankara Bilkent City Hospital. The population is divided into two distinct groups: a Stricture Group (n=30) comprising patients with suspected urethral stricture whose diagnosis is confirmed intraoperatively during scheduled surgery, and a Control Group (n=30) comprising healthy male volunteers with a similar age distribution and no lower urinary tract symptoms. Participants are selected based on their clinical presentation and willingness to undergo a specialized two-stage uroflowmetry protocol.
Descrizione
Inclusion Criteria:
- Male participants aged between 18 and 80 years.
- For the Stricture Group: Patients scheduled for surgery (urethroplasty or internal urethrotomy) due to suspected urethral stricture, where the diagnosis is confirmed intraoperatively.
- For the Control Group: Healthy male volunteers without any lower urinary tract symptoms.
- Voluntary signing of the Informed Consent Form.
Exclusion Criteria:
- Voiding volume less than 150 mL.
- Causes of obstruction other than stricture, such as Benign Prostatic Hyperplasia (BPH).
- Diagnosis of neurogenic bladder dysfunction or a history of neurological disease affecting bladder function.
- Presence of severe comorbidities.
Piano di studio
Come è strutturato lo studio?
Dettagli di progettazione
- Modelli osservazionali: COHORT
- Prospettive temporali: PROSPECTIVE
Numero di gruppi/coorti
Coorti e interventi
Gruppo / CoorteGruppo / Coorte |
Intervento / TrattamentoIntervento / Trattamento |
|---|---|
|
Stricture Group
Patients with suspected urethral stricture scheduled for surgery (urethroplasty or internal urethrotomy), with the diagnosis confirmed intraoperatively. |
Performing natural and forced (Valsalva) uroflowmetry sessions to calculate the Urethral Resistive Index. |
|
Control Group
Healthy male volunteers in a similar age range as the stricture group, without any lower urinary tract symptoms. |
Performing natural and forced (Valsalva) uroflowmetry sessions to calculate the Urethral Resistive Index. |
Cosa sta misurando lo studio?
Misure di risultato primarie
Misure di risultato primarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Urethral Resistive Index (URI)
Lasso di tempo: At the time of the uroflowmetry procedure (Baseline)
|
A novel non-invasive uroflowmetric parameter calculated to assess the resistance of the urethra during voiding. It is derived using the formula: URI=Qmax,natural/Qmax,forced. |
At the time of the uroflowmetry procedure (Baseline)
|
Collaboratori e investigatori
Sponsor
Sponsor
Pubblicazioni e link utili
Pubblicazioni generali
- Kranse R, van Mastrigt R. Bladder outlet resistance. J Urol. 2003 Mar;169(3):1007-10. doi: 10.1097/01.ju.0000052693.58772.23.
- Spyropoulos E, Galanakis I, Deligiannis D, Spyropoulou A, Kotsiris D, Panagopoulos A, Mavrikos S. Flow resistive forces index (QRF): Development and clinical applicability assessment of a novel measure of bladder outlet resistance, aiming to enhance the diagnostic performance of uroflowmetry. Low Urin Tract Symptoms. 2020 Sep;12(3):190-197. doi: 10.1111/luts.12301. Epub 2020 Jan 30.
- Krukowski J, Kaluzny A, Klacz J, Piatkowska A, Matuszewski M. Evaluation of non-invasive tests as diagnostic tools in assessment of bladder outlet obstruction severity in men with anterior urethral stricture. Cent European J Urol. 2021;74(3):422-428. doi: 10.5173/ceju.2021.3.153.R1. Epub 2021 Jul 27.
Studiare le date dei record
Studia le date principali
Inizio studio (Effettivo)
Inizio studio
Completamento primario (Stimato)
Completamento primario
Completamento dello studio (Stimato)
Completamento dello studio
Date di iscrizione allo studio
Primo inviato
Primo inviato
Primo inviato che soddisfa i criteri di controllo qualità
Primo inviato che soddisfa i criteri di controllo qualità
Primo Inserito (Effettivo)
Primo Inserito
Aggiornamenti dei record di studio
Ultimo aggiornamento pubblicato (Effettivo)
Ultimo aggiornamento pubblicato
Ultimo aggiornamento inviato che soddisfa i criteri QC
Ultimo aggiornamento inviato che soddisfa i criteri QC
Ultimo verificato
Ultimo verificato
Maggiori informazioni
Termini relativi a questo studio
Termini MeSH pertinenti aggiuntivi
Altri numeri di identificazione dello studio
Altri numeri di identificazione dello studio
- TABED 1/2090/2026
Piano per i dati dei singoli partecipanti (IPD)
Hai intenzione di condividere i dati dei singoli partecipanti (IPD)?
Descrizione del piano IPD
To protect participant privacy and maintain data confidentiality according to local institutional regulations
Informazioni su farmaci e dispositivi, documenti di studio
Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti
Studia un dispositivo regolamentato dalla FDA degli Stati Uniti
Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .